(Q34771984)

4 August 2017

1 reference

title

Repeat prostate biopsy: who, how and when?. a review (English)

1 reference

4 August 2017

Bob Djavan

1

1 reference

4 August 2017

Mesut Remzi

2

1 reference

4 August 2017

Claude C Schulman

3

1 reference

4 August 2017

Michael Marberger

4

1 reference

4 August 2017

Alexandre R Zlotta

5

1 reference

4 August 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

42

1 reference

4 August 2017

93-103

1 reference

4 August 2017

2

1 reference

Prospective randomized comparison of high energy transurethral microwave thermotherapy versus alpha-blocker treatment of patients with benign prostatic hyperplasia

4 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Is one set of sextant biopsies enough to rule out prostate Cancer? Influence of transition and total prostate volumes on prostate cancer yield

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Making the most out of six systematic sextant biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Three-dimensional computer-assisted analysis of sector biopsy of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Diagnostic value of ten systematic TRUS-guided prostate biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Outcome of laterally directed sextant biopsies of the prostate in screened males aged 50--66 years. Implications for sampling order

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

The influence of prostate size on cancer detection

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Optimization of prostate biopsy strategy using computer based analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Prostatic transition zone biopsies in men with previous negative biopsies and persistently elevated serum prostate specific antigen values

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy?

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Prostate specific antigen density of the transition zone: a new effective parameter for prostate cancer prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

The importance of measuring the prostatic transition zone: an anatomical and radiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Role of PSA and its indices in determining the need for repeat prostate biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Prospective use of free prostate-specific antigen to avoid repeat prostate biopsies in men with elevated total prostate-specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

The value of a single biopsy with 12 transperineal cores for detecting prostate cancer in patients with elevated prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Value of routine transition zone biopsies in patients undergoing ultrasound-guided sextant biopsies for the first time

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Use of repeat sextant and transition zone biopsies for assessing extent of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Spatial distribution of prostate cancers undetected on initial needle biopsies

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Observations on pathology trends in 62,537 prostate biopsies obtained from urology private practices in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Patient tolerance of transrectal ultrasound-guided biopsy of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Multiple transrectal ultrasound-guided prostatic biopsies--true morbidity and patient acceptance

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Side effects and patient acceptability of transrectal biopsy of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Periprostatic local anesthesia before ultrasound-guided prostate biopsy: an update of the miami experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Transrectal biopsy of the prostate and bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

Pathological features of prostate cancer detected on initial and repeat prostate biopsy: results of the prospective European Prostate Cancer Detection study

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2802%2900256-7

7 January 2021

10.1016/S0302-2838(02)00256-7

Identifiers

DOI

1 reference

4 August 2017

1 reference